AzTrials
AzTrials

Dysarthria, HypokineticNCT06815263

Listener Training for Improved Intelligibility of People With Parkinson's Disease

A study testing Listener Training in people with Dysarthria, Hypokinetic, run by Utah State University at 2 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Listener training offers a promising avenue for improving communication for people with dysarthria due to Parkinson's disease by offsetting the intelligibility burden from the patient onto their primary communication partners. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dysarthria, Hypokinetic
What is being tested?
Listener Training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
360 participants
Where
2 sitesUnited States
Study dates
7 Apr 2025to 1 May 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Primary language is English
  • 18 years or older
  • medical diagnosis of Parkinson's disease (patient participants)
  • speech diagnosis of hyperkinetic dysarthria, exhibiting hallmark characteristics (patient participants)

Who cannot join

  • Severe cognitive impairment
  • Less than 18 years of age
  • Primary language other than English

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Morgan Robertson, PhD contact

435-797-1388

morgan.robertson@usu.edu

Stephanie Borrie, PhD contact

435-797-1388

stephanie.borrie@usu.edu

United States2 sites, 2 recruiting
  • Utah State University

    Logan, Utah, 43221

    Stephanie Borrie, PhD, 435-797-1388, stephanie.borrie@usu.edu

    Stephanie Borrie, PhD

    Recruiting
  • Florida State University

    Tallahassee, Florida, 32306

    Kaitlin Lansford, PhD, 850-644-8443, klansford@fsu.edu

    Kaitlin Lansford, PhD

    Recruiting

Other trials in United States

About this study

Listener training offers a promising avenue for improving communication for people with dysarthria due to Parkinson's disease by offsetting the intelligibility burden from the patient onto their primary communication partners. Here, we employ a repeated-measures, randomized controlled trial to establish the efficacy of listener training for patients with PD and their primary communication partners. This translational work will establish a new realm of clinical practice in which the intelligibility impairments in PD are addressed by training partners to better understand dysarthric speech, thus elevating communication outcomes and participation in daily life.

Read the detailed description

People with dysarthria due to Parkinson's disease (PD) frequently present with reduced intelligibility, which can have significant consequences, including reduced participation in situations involving communicating with others and resulting in social isolation.1-5 Few effective treatments exist to ease the intelligibility burden of dysarthria in PD, and most require significant cognitive and physical effort on the part of the speaker to achieve and maintain gains.6,7 Once people with PD have progressed beyond the early stages of the disease, and their cognitive and physical impairments limit their ability to use traditional speech therapy techniques, they are not realistic treatment candidates for current interventions; and no other interventions are available to support their communication. This is a serious and consequential gap in clinical care for people with PD. The current proposal addresses this critical gap by shifting the weight of behavioral change from the speaker to the listener, specifically key communication partners such as family. Indeed, for older adults, most of their time spent with others is spent with family members.8 Further, key partners of patients with PD wish to have a more significant and active role in communication rehabilitation.9,10 A listener-targeted remediation approach for intelligibility impairments in people with dysarthria and PD is firmly grounded in theoretical models of perceptual learning11-13 and rigorously supported by our decade-long research program targeting perceptual learning of dysarthric speech.14-30 To date, this line of investigation has chiefly targeted the theory of listener adaptation to the degraded signal; however, robust intelligibility improvements of up to 20 percent across studies have been observed.15 With a rigorous account of how and what listeners adapt to, we are ideally positioned to move this work from bench to bedside, establishing listener (i.e., perceptual) training as a clinical intervention to improve intelligibility in people with PD. Here, we establish the efficacy of listener training for patients with PD and their primary communication partners using a repeated-measures, randomized controlled trial (SA1). Immediate acquisition and retention of intelligibility improvements will be examined as a function of speaker severity. We then evaluate three theoretically and empirically-motivated communication benefits of listener training that extend beyond intelligibility, including listening effort, comprehension, and communicative participation (SA2). Finally, we engage stakeholder input to inform clinical implementation of listener training using qualitative semi-structured interviews (SA3) with patients with PD and their partners. This will provide insights into the effectiveness and feasibility of the intervention approach, ensuring that their needs and preferences are considered and that they feel empowered and motivated for a listener training approach. Thus, in three independent aims, this proposal will address a current void in our clinical toolbox, establishing a new realm of clinical practice in which communication challenges in PD are managed by training partners to better understand the degraded speech.

Being tested
Listener Training
Keywords
Dysarthria, Parkinson's disease, Speech, Listener
Medical subject headings
Dysarthria, Speech

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Listener TrainingBehavioural

    Partner participants are presented with individual audio phrases that make up passage reading speech stimuli and orthographic transcriptions of what the patient is saying. Partners are asked to listen carefully to the audio files and use the written subtitles to help them understand what is being said.

Study groups in NCT06815263
Study groupRoleWhat they receive
Experimental ConditionExperimentalListener receives speech of patient with dysarthria
Receives: Behavioral: Listener Training
Control conditionSham comparatorListener receives speech of speaker with no speech disorder
Receives: Behavioral: Listener Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Speech intelligibility

    Percent words correct (PWC)

    Measured: pretest, during training, immediate posttest, one week posttest, one month posttest

Secondary outcomes (3)
  1. Listening effort

    Rating scale, 0-100 scale with question "how easy is this speech to understand", with endpoints of 'difficult' on the zero side and 'easy' on the 100 side

    Measured: Pretest, one week posttest, one month posttest

  2. Comprehension

    Story comprehension accuracy score, listeners answer a series of multiple choice comprehension questions, accuracy is defined as how many correct responses they choose for each story

    Measured: Pretest, one week posttest, one month posttest

  3. Communicative Participation Item Bank

    Patient and partner reported summed score across different communication situations

    Measured: Pretest, one month posttest

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2025
  2. Study start7 Apr 2025
  3. Primary completion1 Jan 2029 (estimated)
  4. Study completion1 May 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
360 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06815263
Sponsor's protocol ID
14004
Other IDs
1R01DC020930
Status last verified
Apr 2026
First submitted
3 Feb 2025
Last updated
23 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Listener Training in people with Dysarthria, Hypokinetic, run by Utah State University at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 23 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Morgan Robertson, PhD (435-797-1388, morgan.robertson@usu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Speech intelligibility (time frame: pretest, during training, immediate posttest, one week posttest, one month posttest). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Apr 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in